Safety and Immunogenicity of COVID-19 BBIBP-CorV Vaccine in Children 3-12 Years Old

Greish, K; Alawadhi, A; Jaradat, A; Almarabheh, A; AlMadhi, M; Jawad, J; Alsaffar, B; Alalawi, E; Alsayyad, A; Merza, A; Alalawi, B; Qayed, D; Humaidan, A; Al Qahtani, M

Greish, K (通讯作者)，Arabian Gulf Univ, Coll Med & Med Sci, Manama 329, Bahrain.;Al Qahtani, M (通讯作者)，Bahrain Def Force Hosp, POB 28743, West Riffa, Riffa, Bahrain.;Al Qahtani, M (通讯作者)，Natl Taskforce Combating Coronavirus COVID 19, Manama 329, Bahrain.;Al Qahtani, M (通讯作者)，Ireland Med Univ Bahrain, Royal Collage Surg, Busaiteen 228, Bahrain.

VACCINES, 2022; 10 (4):

Abstract

Background and Objectives: In the current COVID-19 pandemic, children below the age of 12 could manifest COVID-19 symptoms and serve as a reservoir fo......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索